Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial by Altorki, Nasser K, Prof, McGraw, Timothy E, Prof, Borczuk, Alain C, Prof, Saxena, Ashish, MD, Port, Jeffrey L, Prof, Stiles, Brendon M, MD, Lee, Benjamin E, MD, Sanfilippo, Nicholas J, MD, Scheff, Ronald J, MD, Pua, Bradley B, MD, Gruden, James F, Prof, Christos, Paul J, PhD, Spinelli, Cathy, BS, Gakuria, Joyce, MPH, Uppal, Manik, MD, Binder, Bhavneet, MS, Elemento, Olivier, Prof, Ballman, Karla V, Prof, Formenti, Silvia C, Prof

Get full text